InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Koppel Adam, Director. Officer active across 3 companies, notably Dicerna Pharmaceuticals Inc. Cumulatively, 9 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €118.4m. History available since 3 June 2021. The latest transaction was filed on 11 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations9 total
3,282 sharesCommon StockSEC:0000950170-24-090903:0
10,461 sharesCommon StockSEC:0000950170-24-070855:0
904,160 shares@ US$5.53100.0% of flowCommon StockSEC:0000950170-24-004276:0
5,480,052 shares@ US$22.81100.0% of flowCommon StockSEC:0000899243-23-019971:0
Ideal exit: 12 Jul 2024 (T+270)
3,282 sharesCommon StockSEC:0000899243-23-015220:0
3,333 shares@ US$38.2550.0% of flowCommon StockSEC:0000899243-21-050036
3,333 shares@ US$38.2550.0% of flowCommon StockSEC:0000899243-21-050036:0
3,333 shares0Common StockSEC:0000899243-21-022369:0
3,333 shares0Common StockSEC:0000899243-21-022369
9 of 9 declarations
About Koppel Adam
Koppel Adam is a Board Member at Dicerna Pharmaceuticals Inc. He plays an important role in the company's leadership, providing his expertise to guide strategic decisions and foster innovation.
